WO2026013632 - ANTI-NECTIN-4 ANTIBODIES AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/013632
Publication Date
15.01.2026
International Application No.
PCT/IB2025/057034
International Filing Date
11.07.2025
Title **
[English]
ANTI-NECTIN-4 ANTIBODIES AND USES THEREOF
[French]
ANTICORPS ANTI-NECTINE-4 ET LEURS UTILISATIONS
Applicants **
HANGZHOU BAILITE BIOPHARMACEUTICAL CO., LTD.
Inventors
YANG, Ming
ZHONG, Hongyan
LI, Hsieh
GUO, Daniel
NGUYEN, Phuong T.
Priority Data
63/670,507
12.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 6420 | |
| EPO | Filing, Examination, Granting | 142134 | |
| Japan | Filing, Examination, Granting | 5032 | |
| South Korea | Filing, Examination, Granting | 9653 | |
| USA | Filing, Examination, Granting | 37890 |
Total:
201,129
Contact Us
Abstract[English]
This disclosure provides novel heavy chain-only antibodies, bispecific antibodies, multispecific antibodies, and fusion proteins thereof that bind to Nectin Cell Adhesion Molecule 4 (Nectin-4), related antibody-drug conjugates, related nucleic acids, related cells, related kits, related compositions, and related methods or uses.[French]
La présente divulgation concerne de nouveaux anticorps de chaîne lourde unique, des anticorps bispécifiques, des anticorps multispécifiques et des protéines de fusion de ceux-ci qui se lient à la molécule d'adhésion cellulaire de nectine 4 (nectine-4), des conjugués anticorps-médicament associés, des acides nucléiques apparentés, des cellules associées, des kits associés, des compositions associées, et des procédés ou des utilisations associés.